[EN] BRARTEMICIN ANALOGUES<br/>[FR] ANALOGUES DE BRARTÉMICINE
申请人:VICTORIA LINK LTD
公开号:WO2019088854A1
公开(公告)日:2019-05-09
The invention relates to brartemicin analogues of Formula (IV) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben
作者:J. Donald Albright、Vern G. DeVries、Elwood E. Largis、Thomas G. Miner、Marvin F. Reich、Sheldon A. Schaffer、Robert G. Shepherd、Janis Upeslacis
DOI:10.1021/jm00364a009
日期:1983.10
the corresponding esters and sodium salts, are described. The compounds were evaluated in vivo in rats for serum sterol and triglyceride lowering activity and in vitro for activity in inhibiting the principle cholesterol-esterifying enzyme of the arterial wall, fatty acyl-CoA:cholesterol acyltransferase (ACAT). Based on a combination of these two activities, cataben sodium (150) was selected for development
Tunable directional color transition compositions and methods of making and using the same
申请人:Segan Industries, Inc.
公开号:US10168307B1
公开(公告)日:2019-01-01
Color change compositions that transition from a first to second color state upon application of an applied stimulus are provided. Also provided are substrates having the compositions on a surface thereof, as well as methods of making and using the compositions.
Compounds for reducing background color in color change compositions
申请人:Segan Industries, Inc.
公开号:US10570294B2
公开(公告)日:2020-02-25
Aspects of the invention include color change compositions having a color former and color developer composition that transitions from a first color state to a second color state upon application of an applied stimulus and an amount of a copolymer sufficient to eliminate background color of the color former and color developer composition during transition from the first color state to the second color state. Methods for preparing and devices employing the color change compositions of the invention are also described.